Home/Filings/4/0001140361-13-026570
4//SEC Filing

Tribute Pharmaceuticals Canada Inc. 4

Accession 0001140361-13-026570

CIK 0001159019operating

Filed

Jun 26, 8:00 PM ET

Accepted

Jun 27, 7:47 PM ET

Size

11.5 KB

Accession

0001140361-13-026570

Insider Transaction Report

Form 4
Period: 2013-06-24
Transactions
  • Award

    Share Options

    2013-06-24$0.40/sh+90,000$36,000120,000 total(indirect: By affiliate)
    Exercise: $0.40From: 2013-09-30Exp: 2018-06-20Common Shares (90,000 underlying)
Transactions
  • Award

    Share Options

    2013-06-24$0.40/sh+90,000$36,000120,000 total(indirect: By affiliate)
    Exercise: $0.40From: 2013-09-30Exp: 2018-06-20Common Shares (90,000 underlying)
GREGORY JOHN M
Director10% Owner
Transactions
  • Award

    Share Options

    2013-06-24$0.40/sh+90,000$36,000120,000 total(indirect: By affiliate)
    Exercise: $0.40From: 2013-09-30Exp: 2018-06-20Common Shares (90,000 underlying)
Transactions
  • Award

    Share Options

    2013-06-24$0.40/sh+90,000$36,000120,000 total(indirect: By affiliate)
    Exercise: $0.40From: 2013-09-30Exp: 2018-06-20Common Shares (90,000 underlying)
Transactions
  • Award

    Share Options

    2013-06-24$0.40/sh+90,000$36,000120,000 total(indirect: By affiliate)
    Exercise: $0.40From: 2013-09-30Exp: 2018-06-20Common Shares (90,000 underlying)
Footnotes (2)
  • [F1]Actual exercise price will be in Cdn dollars ($0.42).
  • [F2]Options will vest 7,500 the last day of each quarter over the next three years.

Documents

1 file

Issuer

Tribute Pharmaceuticals Canada Inc.

CIK 0001159019

Entity typeoperating
IncorporatedOntario, Canada

Related Parties

1
  • filerCIK 0001159019

Filing Metadata

Form type
4
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 7:47 PM ET
Size
11.5 KB